RESEARCH TRIANGLE PARK, N.C., March 25, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that COSELA™ (trilaciclib) has been added to ...
COSELA Added to Both the NCCN Treatment Guidelines for Small Cell Lung Cancer and the NCCN Supportive Care Guidelines for Hematopoietic Growth Factors RESEARCH TRIANGLE PARK, N.C., March 25, 2021 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results